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Prone breast radiotherapy: a paradigm shift towards 
standard practice? 
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Background and purpose: Whole breast irradiation (WBI) in 
the prone position enables a drastical lung dose reduction 
compared to the standard supine position, however in a small 
subset of patients heart dose is increased in prone position. 
Deep inspiration breath hold (DIBH) has been successfully 
implemented in supine position to reduce heart dose for left-
sided WBI. If the effect of DIBH also occurs in prone position, 
DIBH might further reduce heart dose in the majority of 
patients and may address the problem of higher heart dose in 
prone than supine for the specific subgroup of patients. 
Material and methods: Fifty patients underwent CT-
simulation in prone shallow or normal breathing (SB) and 
prone DIBH; the last 30 patients were accepted for prone 
DIBH treatment. WBI was planned with a median prescription 
dose of 40.05Gy.  
Results: Mean heart dose was lowered from 2.2Gy for prone 
SB to 1.3Gy for prone DIBH (p<0.001), while preserving the 
lung sparing ability of prone positioning. The reductions in 
mean heart dose with DIBH according to breast volume 
<750cc (18 patients), 750-1500cc (22 patients) and >1500cc 
(10 patients) were 1.3 ± 0.9Gy, 0.7 ± 0.7Gy and 0.4 ± 0.4Gy, 
respectively. Prone DIBH nearly consistently reduced mean 
heart dose to <2Gy. All patients were able to perform prone 
positioning while holding their breaths for repetitive periods 
of at least 15 seconds during simulation. Two of the 30 
patients addressed for prone DIBH treatment were eventually 
treated in supine position; one patient with a nearly 
presternal located tumorbed and one patient with severe 
abdominal pain caused by prone positioning during the first 
treatment fraction. None of the prone DIBH treated patients 
developed acute grade III toxicity. 
Conclusions: Prone DIBH combines the heart sparing ability 
of DIBH with a drastic reduction in lung dose due to prone 
positioning. This opens the window for prone treatment in a 
specific subgroup of (small breasted) patients in which higher 
heart doses in prone than supine position were observed. 
These results need to be validated in a confirmatory phase II 
trial.  
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The psycho social aspects of breast cancer must be dealt as a 
whole, not treated separately for each treatment.  In most 
cases, women undergoing radiotherapy suffer considerable 
emotional distress after a devastating diagnostic and side 
effects from surgery and chemotherapy. When they start 
receiving radiotherapy breast cancer patients are in an 
emotional and physical distress. Psycho social issues faced 
are both emotional (fear, depression, low self esteem) and 
social (loss of self image, loss of income) among many others. 
Thus perception of radiotherapy and its impact on the 
patient will depend on how she is living her illness. 
Therefore, the background of each patient must be taken 
into account when planning each treatment.  How can 
Radiation therapists help? Giving the patient information in a 
plain, sensitive language about the treatment, adverse 
effects and tips for counteracting them (nutrition, skin care, 
physical activity), would help reducing anxiety; emotional 
support an inclusive communication in which treatment is 
discussed with the patient would be key to reduce stress. 
Implementing high dose treatment, or even concurrent 
chemotherapy and radiotherapy when possible in order to 
shorten length of treatment and adjusting appointments to 
patient’s needs would also help improve patient experience. 
Key words: psycho social aspects, breast cancer, 
radiotherapy, side effects. 
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Worldwide, there is an increasing interest in particles, such 
as protons and carbon ions as this therapeutic strategy allows 
for highly conformal treatments of deep-seated tumors due 
to the finite range and the inverted depth dose profile 
(Bragg-curve) of charged particles. While for protons the 
more narrow range of RBE results in smaller variations of the 
actual delivered RBE-weighted doses, for carbon ions the 
linear energy transfer (LET) is higher in the Bragg-peak region 
as compared to the beam entrance region (plateau), which 
increases the relative biological effectiveness (RBE) towards 
the distal edge of the depth dose curve. In addition, the 
degree of conformity of charged particles is further enhanced 
by introducing active scanning techniques, which allow dose 
conformation not only at the distal but also at the proximal 
edge of the tumor for each treatment field. Generally, 
particles have demonstrated safety and effectiveness for a 
variety of tumors, showing approximate equivalence of both 
modalities. Yet, randomized controlled multicenter trials on 
large patient cohorts are still pending, which presently makes 
final conclusions rather difficult. 
From the radiobiological point of view, a central demand is 
that treatment planning for carbon ions is performed in terms 
of RBE-weighted rather than absorbed dose. As the depth 
modulation for active techniques is varying throughout the 
complete radiation field, RBEs have to be calculated locally 
at each beam spot. The RBE is a complex quantity, which 
depends on physical parameters such as dose, LET and 
particle type as well as on biological properties like the 
tissue type and the biological endpoint. As complication free 
tumor cure can only be attained, when tumor control 
probability and the risk of morbidity are balanced, the 
impact of high-LET on both, tumor and normal tissues, is 
important.  
To consider the RBE in treatment planning, bio-mathematical 
models are required. In case of patient treatments at GSI/HIT 
using the raster scanning method, all RBEs calculated with 
the Local Effect Model (LEM) are based on normal tissues 
response. Yet, for normal tissues, there exist a presently not 
fully understood relationship between fractionation, spatial 
dose distribution and the clinical outcome of radiation 
therapy. For the validation of these models, the availability 
systematically and consistently collected data for various 
normal tissues is critical. Ultimately, it is the normal tissue 
effect including the risk of secondary cancers, which will 
